Quarterly Activities/Appendix 5B Cash Flow Report
Released
Released
Announcement PDF
ASX Announcement
27 OCTOBER 2022
SEPTEMBER 2022 – QUARTERLY REPORT
Highlights
PARKWAY PROCESS SOLUTIONS (PPS)
§
Industrial Product Range
§
§
§
Continued expansion of industrial water treatment related product range.
Product Development
§
Progressed development of range of modular industrial water treatment systems.
§
Commenced development of commercial-scale ultrapure water systems, suitable for
range of high-value applications, including green hydrogen production.
Business Development
§
Continued success in securing new business from diverse range of companies, for the
provision of industrial water treatment related products, services, and solutions.
PARKWAY PROCESS TECHNOLOGIES (PPT)
§
Continued progress in leveraging proprietary process technology platform to support existing
and emerging business development initiatives in a range of industrial applications.
§
Core Technologies:
§
Ongoing technoeconomic evaluations supporting aMES® commercialisation.
§
Feasibility study based on iBC® technology for QGC Shell is progressing positively,
with several potentially significant opportunities emerging as a result of ongoing study.
§
Mechanical completion of scaled-up New iBC® Pilot Plant, recently completed, with
additional pre and post iBC® processing stages incorporated, enhancing performance.
§
Third-Party Technologies: ongoing evaluations incorporating innovative technologies.
§
Commercialisation Activities: include ongoing technoeconomic evaluations to demonstrate the
substantial operational, financial and sustainability advantages of the technology portfolio.
§
MOU with Middle Eastern EPC to advance salt works feasibility study and target major projects.
PARKWAY CORPORATE (PCL, GROUP)
§
Group sales continue to be underpinned by a growing project backlog, with cash receipts during
the period increasing to $1.22 million.
§
Strong balance sheet with $3.35 million in cash reserves as at 30 September 2022.
§
Cash balance excludes grant funds, R&D tax incentive rebate for FY22 and other receivables.
§
Finalised payment of Contingent Consideration relating to the acquisition of Mawpump Pty Ltd.
Parkway Corporate Limited (“Parkway” or the “Company”) (ASX: PWN) is pleased to report its activities
for the quarter ending 30 September 2022. This report is presented by operating division (strategic
busines unit), as follows:
§
Parkway Process Solutions (PPS)
§
Parkway Process Technologies (PPT)
§
Parkway Ventures (PV)
§
Corporate (Parkway Group)
PARKWAY PROCESS SOLUTIONS (PPS)
Parkway Process Solutions (Parkway Process Solutions Pty Ltd, PPS) is a wholly owned subsidiary
and the primary operating division of the Company.
Business & Corporate Development
Growth of PPS
Parkway continues to strategically expand the operations of PPS, by pursuing a range of commercial
opportunities relating to industrial water and wastewater treatment, predominantly in Australia. With
growing inhouse engineering and technical services capabilities, an innovative product and services
offering, and established operations in Perth, Melbourne and Darwin, PPS is well placed to secure
larger industrial water treatment related opportunities moving forward.
In addition to generating sales through the provision of conventional water treatment solutions, PPS is
increasingly supporting the commercialisation of Parkway’s next-generation technology portfolio,
including the delivery of highly differentiated integrated water treatment and industrial process solutions.
Product Development
In support of a range of new and existing business development activities, PPS continues to progress
the development of modular water treatment capabilities, specifically focused on opportunities for rapid
deployment in high value applications.
As an existing supplier of small-scale ultrapure water (UPW) systems, PPS is leveraging its inhouse
capabilities and expertise, to develop larger capacity, high-performance UPW systems, suitable for a
range of high-value applications, including defence related applications, and green hydrogen
production. Given the growing pipeline of green hydrogen projects and the significant inbound enquiries,
PPS considers the opportunity to supply high-performance UPW systems to be an attractive
opportunity, well suited to the growing capabilities of PPS.
Expanded Operations
In order to support ongoing growth, particularly the planned expansion of fabrication, assembly and
testing related capabilities, during the reporting period, Parkway took possession of two additional
warehouse (with integrated office) facilities:
§
PPS-Perth - in late July, the West Australian operations of Parkway, relocated to a new and
much larger (~2,500 m2) warehouse complex in Bayswater (Perth), incorporating a large
warehouse area, office facilities, store, and a range of laydown areas suitable for the planned
expansion of operations.
§
PPS-Melbourne - in late July, Parkway also took possession of a second warehouse (664 m2)
in the Bunnett Business Park, which given the proximity to the existing PPS warehouse, will
provide a range of operational synergies.
www.pwnps.com
SEPTEMBER 2022
|
QUARTERLY REPORT
|
2
The enlarged warehouse footprint will enable Parkway to significantly expand both the scale and nature
of operations, which will further support Parkway’s aspirations of becoming a leading technology
leveraged industrial water and wastewater treatment company.
Business Development
During the reporting period, PPS continued to improve its market penetration by securing new business
from a diverse range of companies, for the provision of industrial water treatment related products,
services, and solutions. PPS continues to grow its client base, which includes large mining and energy
companies, a diverse range of industrial companies, as well as engineering services, government, and
municipal clients.
Strategic Positioning
In addition to the projects outlined above, PPS continues to progress a broad range of business
development opportunities, including collaborations with several previously foreshadowed companies.
During the reporting period, Parkway continued to focus on strategically important projects, with less of
a focus on short-term revenue generation. Importantly, the growing inhouse product development
capabilities, are increasingly assisting PPS in designing modular water treatment (and related process)
plants, incorporating technologies being commercialised by Parkway Process Technologies (PPT, see
below).
PARKWAY PROCESS TECHNOLOGIES (PPT)
Parkway Process Technologies (Parkway Process Technologies Pty Ltd, PPT) continued to make
significant progress in leveraging its proprietary (core) process technology platform to support existing
and emerging business development initiatives. PPT also continues to make progress with a range of
third-party process technologies, that enable Parkway to provide a broader range of synergistic
industrial process technologies.
Many of the developments outlined in the Parkway Process Solutions (PPS) section, are being pursued,
as they also support the ongoing commercialisation of the PPT technology portfolio. PPT continues to
receive unsolicited enquiries from a range of prospective clients requiring industrial process expertise,
particularly in the field of processing hypersaline brines, including but not limited to potash and lithium
containing brines.
Parkway has previously disclosed an ongoing collaboration with a Middle Eastern EPC (engineeringprocurement-construction) company, focused on exploring the feasibility of expanding the operations
of a major (globally significant) salt works project, to potentially include an integrated downstream
chemical complex. Subject to suitable contractual arrangements being finalised, Parkway expects to
support (through a sub-contract entered into with) the EPC company to provide a range of services,
including process expertise relating to the beneficial processing of hypersaline brines for the recovery
of saleable salt derived products. The EPC company and salt works client are especially interested in
PPT’s range of proprietary technologies, in an effort to achieve the production of a broader and higher
value product mix from the brine resource. Given the prospect of the historical salt works operations,
potentially evolving into a large industrial chemical complex, and the Company’s existing global
strategic partnership with Worley to commercialise both the aMES® and iBC® technologies - a broader
project consortium may be established, as the feasibility study proposal is evaluated by the client.
Following the submission of a suitable feasibility study related proposal to the client, Parkway continued
to provide technical support to the EPC company during the quarter. Subsequent to the reporting period,
the client requested further details and clarifications from Parkway and the EPC company in relation to
the submitted proposal. As a result of the encouraging progress, Parkway and the EPC company have
recently executed a memorandum of understanding (MOU) outlining the collaboration of the parties,
with additional details provided in the Activities Subsequent to Reporting Period, section of this report.
www.pwnps.com
SEPTEMBER 2022
|
QUARTERLY REPORT
|
3
Core Technologies – iBC®
The iBC® technology involves the pre-treatment of complex brines, particularly from the energy, mining
and other industrial sectors, enabling further downstream processing, to reduce wastewater volumes
and potentially recover a range of valuable chemical products.
Recent evaluations continue to provide encouragement that in addition to achieving significant
wastewater volume reductions, the application of the iBC® technology is likely to be able to achieve a
highly desirable zero-liquid discharge (ZLD) solution for certain applications. The advantages of a ZLD
approach, incorporating an iBC® based processing route, also has the potential to create a valuable
revenue stream, through the sale of industrial chemicals, particularly sodium hydroxide.
Following recent agreements centred on the iBC® technology with global engineering company Worley
(10 Feb 2022) and global energy company Shell (7 Apr 2022), the Company is also exploring several
large-scale and high-value applications of the iBC® technology with a range of industrial companies.
New iBC® Pilot Plant
In order to support the ongoing commercialisation of the iBC® technology, a New iBC® Pilot Plant has
been constructed, and has recently achieved mechanical completion. In addition to assisting Parkway
perform larger scale test work, the New iBC® Pilot Plant will also support a range of ongoing commercial
discussions with a range of key stakeholders, including prospective clients and partners.
The feasibility study contract recently awarded to Parkway by QGC Pty Limited (a Shell Group
company), incorporates a range of process piloting related activities, including with the New iBC® Pilot
Plant, as outlined below. In order to further improve operational performance, Parkway has recently
expanded the New iBC® Pilot Plant process train, to incorporate both pre and post processing stages,
which has further improved product quality.
QGC Shell Feasibility Study - Overview
On 7 Apr 2022, Parkway announced it had been awarded a material contract, a feasibility study, by
QGC Pty Limited, a Shell Group company. The material contract is based on Parkway performing a
range of evaluations and assessing the feasibility of treating waste brine derived from two of QGC’s
coal seam gas (CSG) based, water treatment plants, with Parkway’s patented iBC® technology.
Immediately prior to announcing the feasibility study award, Parkway provided an updated market
assessment, indicating that the potential market opportunity for the iBC® technology was in the order of
$307 million/yr, or up to $9.2 billion1 over the life of existing CSG projects operating in Queensland,
Australia. Further details regarding the potential market opportunity for the iBC® technology are outlined
in the 07 Apr 2022 announcement.
QGC Shell Feasibility Study - Experimentation & Engineering
The production of caustic soda (sodium hydroxide) is a key component of the iBC® based flow sheet
being evaluated by Parkway, for the purposes of the feasibility study awarded by QGC Shell. As part of
the iBC® based experimentation and benchtop piloting related activities, Parkway has successfully
produced the first ultrahigh concentration (>50% w/w) sodium hydroxide solution, from a concentrated
waste brine derived from QGC’s CSG wastewater treatment plants.
Parkway has performed extensive experimentation and piloting, in order to establish a range of optimal
process conditions for the proprietary iBC® based flow sheet. These activities are being performed on
concentrated brines sourced from two of QGC’s largest CSG wastewater treatment plants. Once the
optimal process conditions have been established at bench scale, the preferred iBC® based flow sheet
will be validated by performing larger scale piloting, on the New iBC® Pilot Plant.
In parallel to the ongoing experimental and piloting activities, the engineering phase of the feasibility is
well underway, with preparation of a range of engineering deliverables, including datasheets for key
process equipment, with several techno commercial proposals received from major equipment
suppliers (OEMs), predominantly from Europe.
1 Estimates based on evaluations performed by the Company, incorporating information from a range of public and internal sources. These estimates are provided for illustrative purposes
only and should not be relied on for any investment related purposes. All estimates are subject to review, and may be revised or withdrawn, without notice.
www.pwnps.com
SEPTEMBER 2022
|
QUARTERLY REPORT
|
4
Parkway is also collaborating with Worley and QGC Shell, in relation to determining the necessary nonprocess related infrastructure (NPI) required to deliver the project, based on the proposed project
location, an existing QGC Shell industrial site.
QGC Shell Feasibility Study - Additional Opportunities
Ongoing discussions with Shell continue to be highly encouraging, in relation to potential options for
Parkway to assist in the delivery of an industrial process plant based on the iBC® and related proprietary
technologies developed by Parkway, including aMES® related process innovations. These discussions
have also identified a range of potential opportunities beyond the current QGC project, including
significant international opportunities, however such discussions are preliminary in nature, and will likely
depend on the outcomes of the current feasibility study.
Core Technologies – aMES®
The aMES® technology enables the processing of concentrated industrial process and wastewater
streams including brine solutions, to recover a range of valuable compounds, reagents, and fresh water.
In late 2020, Parkway finalised the Karinga Lakes Potash Project – Pre-feasibility Study (KLPP-PFS),
which assisted the Company to demonstrate the significant advantages of the aMES® technology in a
sulphate of potash (SOP) related application. In conjunction with the KLPP-PFS, a new state-of-the-art
aMES® pilot plant was commissioned, providing Parkway with an important process demonstration,
optimisation and validation capability, an essential requirement for successful commercialisation of the
aMES® technology.
The performance data generated by the aMES® pilot plant, is providing important information that will
impact the engineering design of a commercial-scale modularised aMES® plant. An important
advantage of the aMES® technology that is of increasing interest in SOP production, is that the aMES®
technology incorporates a direct induced crystallisation approach, which avoids the requirement for
flotation-based processing. Recent experiences with flotation by various SOP projects under
development in Australia, highlight the challenges associated with flotation-based flow sheets,
particularly when processing feed salts of varying quality, which invariably occurs, when dealing with
natural evaporation derived mixed (KTMS type) salts.
The iBC® feasibility study related activities outlined above, also include a range of aMES® technology
related innovations, in order to achieve optimal project outcomes.
Additional details regarding a proposed feasibility study for a salt works project, which may incorporate
the aMES® technology, are also outlined above.
During the reporting period, Parkway continued to perform a range of aMES® technology related
technoeconomic evaluations as well as engage in discussions with several parties, to further advance
a range of prospective commercial arrangements.
Core Technologies – Other
By leveraging the process engineering capabilities of Parkway, PPT has developed innovative
applications for a range of water and wastewater treatment related processes, to achieve improvements
in the processing and treatment of challenging industrial wastewater streams. Parkway continues to
make progress with several innovative technologies, addressing a range of industrial applications,
particularly complex wastewater streams, associated with large scale energy and mining operations.
Additional target applications include the removal and/or recovery of organic compounds and/or
nutrients from a range of industrial waste streams. In order to advance technology development and
commercialisation targeting this market segment, Parkway will shortly commence a new project titled,
“An integrated water treatment process for valuable nutrient recovery and purification from industrial
waste streams”. This project is supported by Australian Research Council (ARC) funding, with additional
details provided in the Research Grant Funding section of this report.
In addition, Parkway continues to develop new technologies as well as identify additional applications
for its portfolio of proprietary process technologies, to solve high-value problems facing industry.
www.pwnps.com
SEPTEMBER 2022
|
QUARTERLY REPORT
|
5
Third-Party Technologies – Various
As part of efforts to further expand the coverage of Parkway’s cutting-edge technology portfolio,
Parkway is continually evaluating a range of prospective technology platforms. The most attractive
technology platforms are those that not only provide substantial efficiency, financial and sustainability
related advantages over conventional processes, but are also highly complementary with Parkway’s
existing (core) technologies.
During the reporting period, PPT continued to develop and assess the feasibility of a variety of
innovative industrial water treatment related technologies. This process typically incorporates a range
of desktop, experimental and piloting related activities. Encouragingly, Parkway continues to make
strong progress in building a portfolio of technologies, capable of providing a highly integrated process
solution, for a range of wastewater and process streams traditionally considered difficult to treat.
Potential applications for these emerging technologies include, but are not limited to, the treatment of
a range of complex industrial wastewater streams, acid and metalliferous drainage (AMD), municipal
waste streams including landfill leachate.
Commercialisation Activities
Parkway continues to perform a range of evaluations to demonstrate the substantial operational,
financial and sustainability advantages of the technology portfolio, incorporating both the core and thirdparty technologies, as outlined above.
PARKWAY VENTURES (PV)
Parkway Ventures (Parkway Ventures Pty Ltd, PV) holds all resource project and royalty related
interests owned by Parkway.
Karinga Lakes Potash Project (KLPP, 40% working interest)
Parkway currently holds an equity interest in the Karinga Lakes Potash Project (KLPP), through
Parkway Ventures. The KLPP is a joint venture between Verdant Minerals Pty Ltd and Consolidated
Potash Corporation Pty Ltd (a wholly owned subsidiary of Parkway), which is administered through
Territory Potash Pty Ltd (JV Operator).
By way of background, on 05 Nov 2020, Parkway announced completion of the KLPP-PFS, a prefeasibility study based on the strategic application of the aMES® technology. The Company notes the
recent strength in agricultural commodity markets, is supporting elevated fertiliser prices, with the
primary target product from the KLPP, sulphate of potash (SOP), trading significantly higher than the
prices assumed by Parkway in the KLPP-PFS.
Following completion of the KLPP-PFS, a previously disclosed tenement rationalisation process, and
the recent finalisation of joint venture accounting processes, on 24 Jun 2022, Parkway announced it
had satisfied the requisite earn-in requirements, resulting in Parkway increasing its interest in the KLPP
from 15% to 40%.
As at 30 September 2022, exploration tenure for the KLPP project area was held in the three newly
granted exploration licences, details of which are outlined in the Tenement Interests section of this
Quarterly Report, outlined below.
As a result of a joint venture administration related procedures outlined above, during the quarter, no
substantive mining exploration activities occurred in relation to this project.
www.pwnps.com
SEPTEMBER 2022
|
QUARTERLY REPORT
|
6
Mineral Resources
The Mineral Resource Estimate underpinning the KLPP-PFS is summarised below.
Lake
Mineralisation
Contained in Drainable
Porosity
Indicated Mineral
Resource contained in
Total Porosity that meets
reasonable prospects of
economic extraction
Potassium Tonnage
Potassium Tonnage
Potassium Tonnage
(kt)
(kt)
(kT)
580
430
Production
Lakes included in the mine plan (x8)
Sub Total
300
Remaining Lakes (x16)
Sub total
220
430
Totals
520
1000
430
The Mineral Resource estimate underpinning the production targets in this announcement was
prepared by a competent person in accordance with the requirements of the JORC Code 2012.
COMPETENT PERSONS STATEMENT
Parkway reported the Mineral Resource estimate for the Karinga Lakes Potash Project in accordance
with Listing Rule 5.8 in its ASX announcement dated 5 November 2020. Parkway confirms that it is not
aware of any new information or data that materially affects the information included in the
announcement of 5 November 2020 and that all material assumptions and technical parameters
underpinning the estimates in the announcement of 5 November 2020 continue to apply and have not
materially changed.
Other Resource Projects
During the quarter, Parkway continued to consider potential involvement in a number of additional
resource projects, whereby Parkway may contribute its proprietary process technologies related
capabilities, in exchange for Parkway receiving agreed equity interests and/or royalties in the respective
project/s. In the event Parkway is successful in adopting this strategy, Parkway intends to leverage its
technology portfolio to gain economic exposure to additional resources project/s (including, amongst
others, lithium brine projects), without necessarily incurring material balance sheet exposure. For the
avoidance of doubt, this technology commercialisation strategy is consistent with the previously
disclosed innovative business model, being pursued Parkway.
CORPORATE
Quarterly Sales
As a result of ordinary operations, Parkway generated group sales of approximately $0.92 million, with
cash receipts of $1.22 million, underpinned by a growing project backlog with high likelihood of revenue
conversion in the near term.
Given the increasing levels of business development activities described above and the ramp-up period
associated with onboarding new projects, the project backlog provides Parkway with confidence in
relation to building a growing revenue base moving forward.
www.pwnps.com
SEPTEMBER 2022
|
QUARTERLY REPORT
|
7
Funding
During the quarter, Parkway experienced moderate cash outflows ($0.69 million), largely as a result of
ongoing investment in the technology portfolio, expanding the operations of Parkway Process Solutions,
as well as funding work in progress, including the associated build-up of inventory.
Notwithstanding the ongoing investment in a range of strategic initiatives including the expansion of
operations, as at 30 September 2022, Parkway held cash reserves of $3.35 million, excluding i)
undrawn grant funds, ii) R&D rebate for FY22, and iii) other receivables. The strong cash position means
Parkway is well funded to execute its near-term business activities, including the continued roll-out of
PPS, to the point where it is anticipated to make an increasingly significant revenue contribution to the
group.
Research Grant Funding
Parkway has a strong track-record in securing a range of grants, including from the Australian Research
Council (ARC), to support innovative research and development (R&D) and associated
commercialisation related activities. Parkway is regularly invited to participate in several research grant
schemes designed to fund innovative research, which Parkway intends to pursue, where research
interests align, and commercial arrangements are consistent with Parkway’s requirements.
Parkway continues to make progress with several innovative technologies with potential applications in
removal and/or recovery of organic compounds and/or nutrients from a range of industrial waste
streams. In order to assist in funding these R&D related activities, Parkway has recently agreed to
participate in an ARC supported research hub focused on the circular economy. The name of the project
being performed by Parkway is, “An integrated water treatment process for valuable nutrient recovery
and purification from industrial waste streams”. The overall budget for the project developed by
Parkway, is in the order of $1,140,000 (excluding in-kind contributions), over a period of 4 years, where
Parkway will be required to make an annual contribution in the order of $125,000, for the duration of
the project. The balance of project funding ($640,000) will be provided by the ARC and Parkway’s
longstanding research partner Victoria University, leveraging Parkway’s contribution to provide a larger
project budget.
A proportion of the R&D activities performed at Victoria University in collaboration with Parkway,
including the construction, testing and operation of state-of-the-art aMES® and iBC® pilot plants, is
funded by previously awarded grant funding.
Parkway acknowledges the financial support of the Australian Government through the Australian
Research Council.
R&D Rebate
As a technology focused company, Parkway continues to invest in a range of research and development
related initiatives. As a result of these ongoing activities, Parkway expects to receive an Australian
Government research and development tax incentive (R&DTI) payment in relation to eligible activities
performed during FY22, as well as FY23.
Cash on Hand
As at 30 September 2022, the company held $3.35 million in cash reserves. As outlined above, it should
be noted that the reported cash balance excludes, i) undrawn grant funds, ii) the anticipated R&D rebate
for FY22, and iii) other receivables.
Supply Chain Impacts
Parkway continued to experience a range of disruptions during the quarter, including significant delays
in the transportation of key products, including parts. Whilst there have been limited improvements in
transport schedules, these challenges are an industry wide phenomenon and continue to significantly
delay the completion of several awarded projects, and the corresponding recognition of revenues.
www.pwnps.com
SEPTEMBER 2022
|
QUARTERLY REPORT
|
8
Investor Relations
The Parkway Group Managing Director & CEO, Bahay Ozcakmak, provided a number of interviews
during the reporting period. Parkway also released a corporate presentation on 03 Oct 2022, providing
an update on important strategic developments, as well as recent operational performance.
Other Items
As a result of joint venture administration procedures relating to the Karinga Lakes Potash Project
(KLPP, as outlined above), during the quarter, no substantive mining exploration activities occurred in
relation to this project.
During the same period, $0.68 million was incurred in relation to staff costs, $0.43 million in
administration and corporate costs, and $0.80 million for cost of goods sold and additional inventory.
Additional details are provided in the attached Appendix 5B.
Payments to Related Parties
As outlined in the attached Appendix 5B (section 6.1), during the quarter approximately $0.19 million in
payments were made to related parties and their associates for director salaries, consultancy fees,
superannuation, and other related costs.
Tenement Interests
As at 30 September 2022, Parkway held an interest in the following Mineral Exploration Licences
(ELs) held through the KLPP-JV:
Australian Projects – Karinga Lakes Potash Project
Tenement ID
EL32249
EL32250
EL32251
Location
Karinga Lakes
Karinga Lakes
Karinga Lakes
Interest2
40%
40%
40%
State
NT
NT
NT
Activities Subsequent to Reporting Period
MOU with Middle East EPC Company
On 12 October 2022, Parkway entered into an MOU with a Middle Eastern EPC company. The MOU
provides an agreed collaboration framework to pursue a range of common objectives, including:
§
Continued collaboration in relation to pursuing the provision of a feasibility study (subject to
award) for a third-party client, in relation to expanding the operations of a major (globally
significant) salt works project, to potentially include an integrated downstream chemical
complex.
§
Future collaboration in relation to certain target projects, as mutually agreed, which are
predominantly located within the Middle East, and likely to consist of applications involving the
treatment of wastewater generated from utility scale desalinati
Share your feedback
Discover